Natalie C. Ward

机构：Royal Perth Hospital · ORCID：0000-0002-6042-437X

发表论文 186 篇 · 总被引 7561 次 · h-index 47

代表论文

• Click Chemistry-Based Nanomaterial Modification for Cancer Targeting: A Review (2025 · ACS Applied Nano Materials · 被引 15)
• Inhibition of miR-4763-3p expression activates the PI3K/mTOR/Bcl2 autophagy signaling pathway to ameliorate cognitive decline (2024 · International Journal of Biological Sciences · 被引 15)
• Insights into the associations between the gut microbiome, its metabolites, and heart failure (2023 · American Journal of Physiology-Heart and Circulatory Physiology · 被引 15)
• Improved arterial inflammation with high dose omega-3 fatty acids in patients with elevated lipoprotein(a): Selective effect of eicosapentaenoic acid? (2023 · Journal of clinical lipidology · 被引 13)
• An Analysis of the Gut Microbiota and Related Metabolites following PCSK9 Inhibition in Statin-Treated Patients with Elevated Levels of Lipoprotein(a) (2024 · Microorganisms · 被引 9)
• Cascade testing of children and adolescents for elevated Lp(a) in pedigrees with familial hypercholesterolaemia (2023 · Journal of clinical lipidology · 被引 9)